Brief: Pherecydes Pharma Appoints Didier Hoch As Chairman And CEO

Pherecydes Pharma SA

23/05/2022 17:21

May 23 (Reuters) - Pherecydes Pharma SA  ALPHE.PA :
    * THE GENERAL ASSEMBLY OF PHERECYDES PHARMA APPROVES THE
EVOLUTION
OF ITS GOVERNANCE TOWARDS A COMPANY WITH A BOARD OF DIRECTORS
    * NEW BOARD OF DIRECTORS HAS APPOINTED DIDIER HOCH AS
CHAIRMAN AND
CEO, AND THIBAUT DU FAYET AS DEPUTY CEO
    * BOARD OF DIRECTORS IS THUS COMPOSED OF 7 MEMBERS, 2 OF
WHOM ARE
INDEPENDENT
    * IT IS ALSO ENVISAGED TO ADOPT, AT A LATER STAGE, A
SEPARATION OF
FUNCTIONS OF CHAIRMAN OF BOARD OF DIRECTORS AND CEO AND THUS TO
APPOINT A NEW CEO
    * TERMINATION OF FUNCTIONS OF MR. GUY-CHARLES FANNEAU DE LA
HORIE,
PREVIOUSLY CHAIRMAN OF EXECUTIVE BOARD, WHO DID NOT WISH, FOR
PERSONAL REASONS, TO ASSUME MANDATE OF CEO IN NEW GOVERNANCE
    * BOARD HAS NOT DECIDED TO ADOPT, AT THIS STAGE, A
SEPARATION OF
FUNCTIONS OF CEO AND CHAIRMAN OF BOARD OF DIRECTORS

Source text for Eikon:  urn:newsml:reuters.com:*:nBwbjqL5Sa
Further company coverage:  ALPHE.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))